HK1254168A1 - 用於治療皰疹病毒誘導的病況的方法和組合物 - Google Patents
用於治療皰疹病毒誘導的病況的方法和組合物Info
- Publication number
- HK1254168A1 HK1254168A1 HK18113305.3A HK18113305A HK1254168A1 HK 1254168 A1 HK1254168 A1 HK 1254168A1 HK 18113305 A HK18113305 A HK 18113305A HK 1254168 A1 HK1254168 A1 HK 1254168A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- methods
- induced conditions
- treating herpesvirus
- herpesvirus induced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562182071P | 2015-06-19 | 2015-06-19 | |
PCT/US2016/038148 WO2016205695A1 (en) | 2015-06-19 | 2016-06-17 | Methods and compositions for treating herpesvirus induced conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1254168A1 true HK1254168A1 (zh) | 2019-07-12 |
Family
ID=57546411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113305.3A HK1254168A1 (zh) | 2015-06-19 | 2018-10-17 | 用於治療皰疹病毒誘導的病況的方法和組合物 |
Country Status (6)
Country | Link |
---|---|
US (3) | US20180185345A1 (zh) |
EP (1) | EP3310168B1 (zh) |
JP (2) | JP7366385B2 (zh) |
CN (2) | CN108347929A (zh) |
HK (1) | HK1254168A1 (zh) |
WO (1) | WO2016205695A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
EA202090764A1 (ru) * | 2017-12-08 | 2020-08-03 | Борис Славинович ФАРБЕР | Фармацевтическая композиция для элиминации возбудителей герпесвирусных инфекций из тканей макроорганизма |
JP7194458B2 (ja) | 2018-07-19 | 2022-12-22 | 国立大学法人大阪大学 | ウイルス計測方法、ウイルス計測装置、およびストレス判定装置 |
JP2022536256A (ja) * | 2019-05-31 | 2022-08-15 | ヴィラクタ サブシディアリー,インク. | ヒストンデアセチラーゼ阻害剤を用いてウイルス関連癌を治療する方法 |
WO2020243326A1 (en) * | 2019-05-31 | 2020-12-03 | Viracta Therapeutics, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
CN114306313B (zh) * | 2019-07-18 | 2023-06-16 | 北京市农林科学院 | 克拉屈滨在抑制犬细小病毒中的应用 |
CN112294810B (zh) * | 2019-07-29 | 2024-03-01 | 深圳微芯生物科技股份有限公司 | 含有西达本胺和表面活性剂的药物组合物 |
CN112569243A (zh) * | 2019-09-30 | 2021-03-30 | 神农医药科技有限公司 | 制备治疗阿尔茨海默病的药物 |
JP2022552642A (ja) * | 2019-10-07 | 2022-12-19 | ヴィラクタ サブシディアリー,インク. | 副作用が軽減されたhdac治療の調剤 |
CN111187751A (zh) * | 2020-01-19 | 2020-05-22 | 中国农业科学院兰州兽医研究所 | 一种用于构建幼畜心肌炎细胞模型的细胞系及构建方法 |
CN112111006B (zh) * | 2020-08-27 | 2022-06-07 | 北京弘进久安生物科技有限公司 | 抗牛结节性皮肤病病毒的抗体、检测试纸及试剂盒 |
EP4232076A1 (en) * | 2020-10-20 | 2023-08-30 | The Chancellor, Masters and Scholars of The University of Oxford | Methods and compositions for treating epstein barr virus-associated cancer |
CN112877275B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac2基因敲除的bhk-21细胞系及其构建方法和应用 |
CN112980878B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac8基因敲除的bhk-21细胞系及其构建方法和应用 |
WO2023244968A1 (en) * | 2022-06-13 | 2023-12-21 | Viracta Subsidiary, Inc. | Methods of treating autoimmune disorders with histone deacetylase inhibitors |
WO2024112712A1 (en) * | 2022-11-21 | 2024-05-30 | Henderson Theodore | Treatment using an antiviral compound and spironolactone |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4747825A (en) | 1984-06-29 | 1988-05-31 | Ferring Laboratories, Inc. | Apparatus and methodology for pulsed administration of growth promoting agents |
US4948592A (en) | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
US4723958A (en) | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
US4965251A (en) | 1987-04-03 | 1990-10-23 | The Board Of Regents Of The University Of Washington | Pulse treatment of hemoglobinopathies with erythropoietin |
US5766573A (en) | 1988-12-06 | 1998-06-16 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5190029A (en) | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
US5376359A (en) | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
US5403590A (en) | 1992-12-21 | 1995-04-04 | New England Deaconess Hospital Corporation | Method of pulsatile drug infusion |
US20110086869A1 (en) * | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
WO2011113013A2 (en) * | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
MX365393B (es) * | 2011-09-13 | 2019-05-31 | Pharmacyclics Llc | Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas. |
WO2014074952A1 (en) * | 2012-11-09 | 2014-05-15 | Massachusetts Institute Of Technology | Methods and compositions for localized delivery of agents to hiv-infected cells and tissues |
CN104083763A (zh) * | 2014-07-16 | 2014-10-08 | 中国人民解放军军事医学科学院野战输血研究所 | 组蛋白去乙酰化酶抑制剂在制备潜伏病毒激活剂中的应用 |
-
2016
- 2016-06-17 CN CN201680046420.0A patent/CN108347929A/zh active Pending
- 2016-06-17 JP JP2017565967A patent/JP7366385B2/ja active Active
- 2016-06-17 WO PCT/US2016/038148 patent/WO2016205695A1/en active Application Filing
- 2016-06-17 CN CN202310699709.4A patent/CN116712552A/zh active Pending
- 2016-06-17 EP EP16812548.2A patent/EP3310168B1/en active Active
- 2016-06-17 US US15/737,701 patent/US20180185345A1/en not_active Abandoned
-
2018
- 2018-10-17 HK HK18113305.3A patent/HK1254168A1/zh unknown
-
2020
- 2020-03-30 US US16/835,122 patent/US20210046061A1/en not_active Abandoned
-
2021
- 2021-12-24 JP JP2021211486A patent/JP2022058416A/ja active Pending
-
2023
- 2023-06-07 US US18/206,947 patent/US20240041848A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3310168B1 (en) | 2024-08-21 |
JP2022058416A (ja) | 2022-04-12 |
JP7366385B2 (ja) | 2023-10-23 |
US20240041848A1 (en) | 2024-02-08 |
CN108347929A (zh) | 2018-07-31 |
CN116712552A (zh) | 2023-09-08 |
US20180185345A1 (en) | 2018-07-05 |
WO2016205695A1 (en) | 2016-12-22 |
EP3310168A4 (en) | 2019-03-06 |
JP2018517757A (ja) | 2018-07-05 |
US20210046061A1 (en) | 2021-02-18 |
EP3310168A1 (en) | 2018-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254168A1 (zh) | 用於治療皰疹病毒誘導的病況的方法和組合物 | |
HK1243640A1 (zh) | 用於治療潰瘍的方法和組合物 | |
IL304820A (en) | Preparations and methods for the treatment of cancer | |
IL278004A (en) | Methods and preparations for treating conditions related to aging | |
PT3377516T (pt) | Composição para o tratamento do cancro | |
IL251759A0 (en) | Preparations and methods for treating insomnia | |
GB2558326B (en) | Methods and compositions for inhibiting and treating neurological conditions | |
PL3200815T3 (pl) | Sposoby i kompozycje do leczenia nowotworu | |
HUE054204T2 (hu) | Összetételek és módszerek gyulladások kezeléséhez és megelõzéséhez | |
IL256523A (en) | Compositions and methods for treating cancer | |
HK1246206A1 (zh) | 用於治療青光眼的組合物和方法 | |
EP3262065C0 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSTROGLYCANOPATHY DISEASES | |
HUE060394T2 (hu) | Készítmények és módszerek az endometriózis kezelésére | |
IL255638A (en) | Compositions and methods for treating cancer | |
HK1244782A1 (zh) | 用於治療疾病和病癥的組合物和方法 | |
ZA201802268B (en) | Methods and compositions for preventing or treating cancer | |
HK1250958A1 (zh) | 用於治療癌症的組合物和方法 | |
IL257407A (en) | Compositions and methods for treating wounds | |
PT3519050T (pt) | Composições para o tratamento de condições oftálmicas | |
GB201521083D0 (en) | Compositions for treatment and methods thereof |